Sunteți pe pagina 1din 5

To, Dr. Shailesh A. Shah BODYLINE HOSPITALS, Opp.

Annapurna Hall, Besides Dev Status, Nawa Vikas Gruh Road, Paldi, Ahmedabad - 380007, Gujarat, India. Reference: Protocol No. SLS/SAH/01/2012 FOUNTAIN Trial: A randomized open label dose determination clinical study to evaluate the safety and efficacy of Capsule Outflo in patients with Benign Prostatic Hyperplasia. Subject: Site Audit Visit on 22nd & 23rd Feb 2013 Dear Dr. Shailesh A. Shah Greetings from the SAHAJANAND LIFE SCIENCES PVT LTD We are extremely thankful to you for your support extended towards us in FOUNTAIN trial till to date. We appreciate your commitment and cooperation in FOUNTAIN TRIAL. This is to notify you that we have scheduled the site audit visit at your site on 22nd & 23rd Feb 2013 This will be 2 day audit visit. I will be accompanied by Dr. Nirav Joshi during the visit. During the visit following activities will be performed Verification of Informed consent process and documentation Source document verification eCRF data entry verification Review of records in Site Master File IP accountability Verification of study related logs However it is not necessary that we will check records for all the patients enrolled in FOUNTAIN trial. We may randomly pick the subject for the verification. In case you require any further information or clarification regarding the above you may contact me on +91 9099046165 Thanking you in anticipation, Mr. Dipak Patel

R&D Manager SAHAJANAND LIFE SCIENCES PVT LTD

To, Dr. Rasesh Desai DESAI UROLOGICAL AND MATERNITY HOSPITAL 2nd and 3rd Floor Abhinav Complex Kamalkunj Society, Delux Circle, Nizampura, Vadodra - 390002 Reference: Protocol No. SLS/SAH/01/2012 FOUNTAIN Trial: A randomized open label dose determination clinical study to evaluate the safety and efficacy of Capsule Outflo in patients with Benign Prostatic Hyperplasia. Subject: Site Audit Visit on 20th Feb 2013 Dear Dr. Rasesh Desai Greetings from the SAHAJANAND LIFE SCIENCES PVT LTD We are extremely thankful to you for your support extended towards us in FOUNTAIN trial till to date. We appreciate your commitment and cooperation in FOUNTAIN TRIAL. This is to notify you that we have scheduled the site audit visit at your site on 20 th Feb 2013 This will be 1 day audit visit. I will be accompanied by Dr. Nirav Joshi during the visit. During the visit following activities will be performed Verification of Informed consent process and documentation Source document verification eCRF data entry verification Review of records in Site Master File IP accountability Verification of study related logs However it is not necessary that we will check records for all the patients enrolled in FOUNTAIN trial. We may randomly pick the subject for the verification. In case you require any further information or clarification regarding the above you may contact me on +91 9099046165 Thanking you in anticipation, Mr. Dipak Patel

R&D Manager SAHAJANAND LIFE SCIENCES PVT LTD

To, Dr. Ravindra Bhalchandra Sabnis MULJIBHAI PATEL UROLOGICAL HOSPITAL (KIDNEY HOSPITAL) Dr. Virendra Desai Road, Nadiad 387001, Gujarat, India. Reference: Protocol No. SLS/SAH/01/2012 FOUNTAIN Trial: A randomized open label dose determination clinical study to evaluate the safety and efficacy of Capsule Outflo in patients with Benign Prostatic Hyperplasia. Subject: Site Audit Visit on 2nd March 2013 Dear Dr. Sabnis Greetings from the SAHAJANAND LIFE SCIENCES PVT LTD We are extremely thankful to you for your support extended towards us in FOUNTAIN trial till to date. We appreciate your commitment and cooperation in FOUNTAIN TRIAL. This is to notify you that we have scheduled the site audit visit at your site on 2 nd March 2013 This will be 1 day audit visit. I will be accompanied by Dr. Nirav Joshi during the visit. During the visit following activities will be performed Verification of Informed consent process and documentation Source document verification eCRF data entry verification Review of records in Site Master File IP accountability Verification of study related logs However it is not necessary that we will check records for all the patients enrolled in FOUNTAIN trial. We may randomly pick the subject for the verification. In case you require any further information or clarification regarding the above you may contact me on +91 9099046165 Thanking you in anticipation, Mr. Dipak Patel

R&D Manager SAHAJANAND LIFE SCIENCES PVT LTD

To, Dr. Vijay D. Raghoji DR. RAGHOJI KIDNEY HOSPITAL AND RESEARCH CENTRE PRIVATE LIMITED 146/2 Railway Lines, Near Old R.T.O., Solapur 413001, Maharashtra. Reference: Protocol No. SLS/SAH/01/2012 FOUNTAIN Trial: A randomized open label dose determination clinical study to evaluate the safety and efficacy of Capsule Outflo in patients with Benign Prostatic Hyperplasia. Subject: Site Audit Visit on 12th March 2013 Dear Dr. Raghoji, Greetings from the SAHAJANAND LIFE SCIENCES PVT LTD!!! We are extremely thankful to you for your support extended towards us in FOUNTAIN trial till to date. We appreciate your commitment and cooperation in FOUNTAIN TRIAL. This is to notify you that we have scheduled the site audit visit at your site on 12th March 2013. This will be 1 day audit visit. I will be accompanied by Dr. Nirav Joshi during the visit. During the visit following activities will be performed Verification of Informed consent process and documentation Source document verification eCRF data entry verification Review of records in Site Master File IP accountability Verification of study related logs However it is not necessary that we will check records for all the patients enrolled in FOUNTAIN trial. We may randomly pick the subject for the verification. In case you require any further information or clarification regarding the above you may contact me on +91 9099046165 Thanking you in anticipation, Mr. Dipak Patel

R&D Manager SAHAJANAND LIFE SCIENCES PVT LTD

To, Dr. Gyanendra R. Sharma CHITALE CLINIC PRIVATE LIMITED 165 D Railway Lines, Saat Rasta, Opposite Bus Stand, Solapur 413001, Maharashtra. Reference: Protocol No. SLS/SAH/01/2012 FOUNTAIN Trial: A randomized open label dose determination clinical study to evaluate the safety and efficacy of Capsule Outflo in patients with Benign Prostatic Hyperplasia. Subject: Site Audit Visit on 12th March 2013 Dear Dr. Sharma, Greetings from the SAHAJANAND LIFE SCIENCES PVT LTD!!! We are extremely thankful to you for your support extended towards us in FOUNTAIN trial till to date. We appreciate your commitment and cooperation in FOUNTAIN TRIAL. This is to notify you that we have scheduled the site audit visit at your site on 12th March 2013. This will be 1 day audit visit. I will be accompanied by Dr. Nirav Joshi during the visit. During the visit following activities will be performed Verification of Informed consent process and documentation Source document verification eCRF data entry verification Review of records in Site Master File IP accountability Verification of study related logs However it is not necessary that we will check records for all the patients enrolled in FOUNTAIN trial. We may randomly pick the subject for the verification. In case you require any further information or clarification regarding the above you may contact me on +91 9099046165 Thanking you in anticipation, Mr. Dipak Patel

R&D Manager SAHAJANAND LIFE SCIENCES PVT LTD

S-ar putea să vă placă și